| Dr Andrea Lynn Stevens, AUD | |
|
921 Ne 13th St, Oklahoma City, OK 73104-5007 | |
| (405) 270-0501 | |
| Not Available |
| Full Name | Dr Andrea Lynn Stevens |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 921 Ne 13th St, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548208317 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 347 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrea Lynn Stevens, AUD 5925 W 7th Ave, Stillwater, OK 74074-1160 Ph: (405) 270-0501 | Dr Andrea Lynn Stevens, AUD 921 Ne 13th St, Oklahoma City, OK 73104-5007 Ph: (405) 270-0501 |
News Archive
Among the general U.S. population, people who are uninsured are about half as likely to receive critical care services as those with insurance, according to systematic review of the literature by the American Thoracic Society's Health Disparities Group.
Sirona, the dental technology leader, today announced its financial results for the quarter and fiscal year ended September 30, 2010.
A phase III clinical trial conducted at the Meir Medical Center in Kfar-Saba, Israel is now recruiting participants to study the effects of dietary supplement PectaSol-C modified citrus pectin (MCP) in controlling prostate specific antigen (PSA) levels in prostate cancer patients.
Scientists may have developed the first targeted, oral, tumor-type agnostic therapy - a cancer medicine that works comparably well across many kinds of cancer, regardless of patient age. In clinical trials of adults and children with 17 different types of advanced cancer, larotrectinib treatment resulted in responses in 76% of patients.
Massachusetts General Hospital (MGH) and the Iacocca Foundation announce today the completion of the Phase I BCG clinical trial in type 1 diabetes, as well as the submission of all safety reports to the U.S. Food and Drug Administration (FDA) and the MGH data safety monitoring boards. Plans for the Phase II clinical study, which will continue the investigation of bacillus Calmette-Guerin (BCG) vaccination as a treatment for people with existing type 1 diabetes, are actively underway.
› Verified 7 days ago
Mrs. Farris Ree Stroupe, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4140 W. Memorial Rd Suite 116, Oklahoma City, OK 73120 Phone: 405-755-1930 | |
Kristen Macdougall Bybee, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1200 Childrens Ave # 8c, Oklahoma City, OK 73104 Phone: 405-271-2662 | |
Kerri Anne Conley, M.S. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3400 Nw 56th St, Oklahoma City, OK 73112 Phone: 405-949-1906 | |
Dr. Elizabeth Ann Harder, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 535 Nw 9th St, Suite 305, Oklahoma City, OK 73102 Phone: 405-272-6027 | |
Ms. Esther H Kim, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 11500 N Portland Ave, Oklahoma City, OK 73120 Phone: 405-548-4300 Fax: 405-548-4349 | |
Dr. Elizabeth Ruth Elliott, AU.D., M.B.A. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 921 Ne 13th St, Oklahoma City, OK 73104 Phone: 405-270-0501 Fax: 405-552-4365 | |
Jace A Wolfe, PHD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 11500 N Portland Ave, Oklahoma City, OK 73120 Phone: 405-548-4300 |